North America: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Colorado Judge Quashes DOJ Gender-Related Care Subpoena

On January 5, 2026, District of Colorado Magistrate Judge Cyrus Chung issued a recommendation that the district court grant a motion to quash a Department of Justice (DOJ)...

United States Healthcare

CM

Crowell & Moring LLP

Federal Legislative Update: Momentum Builds Around Medicare Site-Neutral Payment Policies

Washington policymakers are increasingly aligned around expanding Medicare "site-neutral" payment policies in 2026...

United States Healthcare

NM

Nelson Mullins Riley & Scarborough LLP

The New Playbook For Competitive Life Sciences M&A — How Buyers Can Differentiate Beyond Price Through Structure And Strategy

The life sciences M&A market is reemerging in 2026 as a competitive arena for strategic buyers, after several years of subdued activity. Large pharmaceutical and biotech buyers are pursuing strategic...

United States Healthcare

GP

Goodwin Procter LLP

Year In Review: Big Deals Of 2025

As we head into what is anticipated to be a strong year for biopharma dealmaking, we look back at some of the biggest deals in 2025 that focus on biologics and biosimilars.

United States Healthcare

GP

Goodwin Procter LLP

Life Sciences Capital Markets: Preparing For Your 2026 IPO

United States Healthcare

GP

Goodwin Procter LLP

Looking Ahead: Key LTC CON And PACE Topics For 2026 (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS-OIG Issues Unfavorable Advisory Opinion On Sign-On Bonuses For Home Care Agency Attendants

United States Healthcare

BT

Barnes & Thornburg LLP

Food Venture Financing News – Weekly Issue No. 266

United States Healthcare

DW

Davis Wright Tremaine

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Humana And Mark Cuban Exploring Potential Pharmacy Partnership

United States Healthcare

HB

Hall Benefits Law

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

DEA And HHS Extend Telemedicine Prescribing Flexibilities Through 2026

United States Healthcare

HK

Holland & Knight

Bipartisan Senate Finance Committee Leaders Reintroduce PBM Regulation Bill

United States Healthcare

HB

Hall Benefits Law

Recent Enforcement Cases In China Life Sciences Compliance

United States Healthcare

AP

Arnold & Porter

Artificial Intelligence — A Blessing With Boundaries (Video)

United States Technology

MB

Michael Best

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

Visa Turbulence: Navigating Your H-1B Future In A Shifting U.S. Landscape (Video)

United States Immigration

Gs

Green and Spiegel

The Empty Chair At Johannesburg: What It Says About US Power

United States International

SJ

Steptoe LLP

Food Venture Financing News – Weekly Issue No. 263

United States Healthcare

DW

Davis Wright Tremaine

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

The New Playbook For Competitive Life Sciences M&A — How Buyers Can Differentiate Beyond Price Through Structure And Strategy

The life sciences M&A market is reemerging in 2026 as a competitive arena for strategic buyers, after several years of subdued activity. Large pharmaceutical and biotech buyers are pursuing strategic...

United States Healthcare

GP

Goodwin Procter LLP

Year In Review: Big Deals Of 2025

As we head into what is anticipated to be a strong year for biopharma dealmaking, we look back at some of the biggest deals in 2025 that focus on biologics and biosimilars.

United States Healthcare

GP

Goodwin Procter LLP

Life Sciences Capital Markets: Preparing For Your 2026 IPO

The life sciences industry is poised for an upswing in initial public offering (IPO) activity in 2026, supported by a large IPO backlog...

United States Healthcare

GP

Goodwin Procter LLP

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

FDA Is Open To The Idea Of Possible Regulatory Flexibility For Cell And Gene Therapies On A Case-by-Case Basis…Where Appropriate

United States Healthcare

HP

Hyman, Phelps, & McNamara

Turning Insight Into Action: A Life Sciences Playbook For 2026

United States Commercial

PL

Polsinelli LLP

Telehealth Update: Telehealth Flexibilities, Convictions And Indictment, And 2026 Outlook

United States Healthcare

M

Mintz

Holland & Knight Health Dose: January 6, 2026

United States Healthcare

HK

Holland & Knight

See more

Healthcare

Kentucky Supreme Court Clarifies Privilege For Hospital Incident Reports And Root Cause Analyses

On December 18, 2025, the Supreme Court of Kentucky clarified when internal hospital investigations and reports are protected from discovery under the federal Patient Safety and Quality Improvement Act ("PSQIA")...

United States Litigation

SH

Stites & Harbison PLLC

Colorado Judge Quashes DOJ Gender-Related Care Subpoena

On January 5, 2026, District of Colorado Magistrate Judge Cyrus Chung issued a recommendation that the district court grant a motion to quash a Department of Justice (DOJ)...

United States Healthcare

CM

Crowell & Moring LLP

Federal Legislative Update: Momentum Builds Around Medicare Site-Neutral Payment Policies

Washington policymakers are increasingly aligned around expanding Medicare "site-neutral" payment policies in 2026...

United States Healthcare

NM

Nelson Mullins Riley & Scarborough LLP

Looking Ahead: Key LTC CON And PACE Topics For 2026 (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS-OIG Issues Unfavorable Advisory Opinion On Sign-On Bonuses For Home Care Agency Attendants

United States Healthcare

BT

Barnes & Thornburg LLP

Service Of Process: More Than A Formality

Canada Litigation

C

Cassels

NYC Expands Construction Safety Training To Include Mental Health

United States Employment

JL

Jackson Lewis P.C.

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Humana And Mark Cuban Exploring Potential Pharmacy Partnership

United States Healthcare

HB

Hall Benefits Law

See more

Food and Drugs Law

Colorado Judge Quashes DOJ Gender-Related Care Subpoena

On January 5, 2026, District of Colorado Magistrate Judge Cyrus Chung issued a recommendation that the district court grant a motion to quash a Department of Justice (DOJ)...

United States Healthcare

CM

Crowell & Moring LLP

Year In Review: Big Deals Of 2025

As we head into what is anticipated to be a strong year for biopharma dealmaking, we look back at some of the biggest deals in 2025 that focus on biologics and biosimilars.

United States Healthcare

GP

Goodwin Procter LLP

Service Of Process: More Than A Formality

Plaintiffs usually start lawsuits by serving the defendant personally with a statement of claim. While personal service is the "gold standard," Ontario's Rules of Civil Procedure permit alternative...

Canada Litigation

C

Cassels

Food Venture Financing News – Weekly Issue No. 266

United States Healthcare

DW

Davis Wright Tremaine

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Humana And Mark Cuban Exploring Potential Pharmacy Partnership

United States Healthcare

HB

Hall Benefits Law

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

DEA And HHS Extend Telemedicine Prescribing Flexibilities Through 2026

United States Healthcare

HK

Holland & Knight

Bipartisan Senate Finance Committee Leaders Reintroduce PBM Regulation Bill

United States Healthcare

HB

Hall Benefits Law

See more

Latest Videos

See more

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More